Publications

Joint Statement on the Hospital Exemption for ATMPs

9 October, 2025/by Adel Medzikovic

Newsletter September 2025

9 October, 2025/by Adel Medzikovic

Publication: Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe

29 September, 2025/by Adel Medzikovic

Publication office of the EU: Study on the hospital exemption

12 August, 2025/by Adel Medzikovic

Registration DARE-NL Annual Consortium Meeting 2025 [registration closed]

12 March, 2025/by Simone Punt

Registration open for NVGCT meeting on 10-11 June 2025

20 February, 2025/by Adel Medzikovic

KCE report on ‘Academic development of ATMPs in Belgium – an exploratory study of the legal and strategic options’

30 January, 2025/by Adel Medzikovic

FAST’s webinar series on challenges in ATMP innovation (11, 18 and 25 March 2025)

22 January, 2025/by Adel Medzikovic

Report of the RSNN SIG Advanced Therapies and FAST workshop

20 December, 2024/by Adel Medzikovic

Information by the ZIN about the new European HTA legislation (in Dutch)

10 December, 2024/by Adel Medzikovic

Launch of new guidebook for ATMP developers by FAST

21 November, 2024/by Adel Medzikovic

Two new EMA documents on regulatory science

14 November, 2024/by Adel Medzikovic

Rapport Academie-gedreven geneesmiddelenontwikkeling door SiRM (in Dutch)

17 October, 2024/by Adel Medzikovic

Behandeling van kanker in een vroeg stadium met innovatieve geneesmiddelen: wat is het ons waard? (in Dutch)

8 October, 2024/by Adel Medzikovic

Pictures annual DARE-NL meeting 2024

1 October, 2024/by Adel Medzikovic

Overzicht early access programma’s door Hollandbio (in Dutch)

3 September, 2024/by Adel Medzikovic

The Value of Gene Therapy. A study of the growth, cost and accessibility of gene therapy products (in English and Dutch)

25 June, 2024/by Simone Punt

Anke Hövels, KWF: Samen voor betere behandeling voor elke patiënt met kanker (in Dutch)

30 May, 2024/by Simone Punt

NTvH interview met Dr. Trudy Straetemans over DARE-NL (in Dutch)

8 May, 2024/by Simone Punt

Is the proposed EU General Pharmaceutical Legislation ready to support pharmaceutical innovation?

30 April, 2024/by Simone Punt

Rapport Verkenning aanvaardbaar risico gentherapieonderzoek (in Dutch)

14 March, 2024/by Adel Medzikovic

NTvH artikel ‘DARE-NL: Nederlands platform voor snellere toegang tot ATMP’s bij kanker’ (in Dutch)

2 March, 2024/by Adel Medzikovic

Article in BJCP: ‘EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells’

15 February, 2024/by Adel Medzikovic

Dashboard Doorlooptijden Geneesmiddelen opgezet door VWS (in Dutch)

2 February, 2024/by Adel Medzikovic

Boek uitgebracht over gen- en celtherapie (in Dutch)

2 February, 2024/by Adel Medzikovic

Kamerbrief ‘Stimuleren innovatieve geneesmiddelenontwikkeling’ (in Dutch)

19 December, 2023/by Adel Medzikovic

Rapport van het Rathenau instituut ‘De genen waar het om gaat – Een verkenning van maatschappelijk verantwoorde ontwikkeling van gentherapie’ (in Dutch)

18 December, 2023/by Adel Medzikovic

Rapport ‘Geneesmiddelen voor Geavanceerde Therapie (ATMP’s) in Nederland: Veldverkenning, Knelpuntanalyse en Activiteitenkaart’ (in Dutch)

1 December, 2023/by Adel Medzikovic

Article in Journal of Clinical Oncology: ‘Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed’

27 November, 2023/by Adel Medzikovic

Review article in Frontiers in Immunology: ‘Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations’

24 November, 2023/by Adel Medzikovic

Review article in IOTECH: ‘Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit’

13 October, 2023/by Adel Medzikovic

Artikel over ATMP therapie in Pharmaceutisch Weekblad (in Dutch)

3 October, 2023/by Adel Medzikovic

Kamerbrief ‘Verkenning naar de mogelijkheden tot het verminderen van de (financiële) obstakels bij drug repurposing’ (in Dutch)

4 August, 2023/by Adel Medzikovic

Interview DARE-NL Management Team (in Dutch)

15 May, 2022/by admin

KWF lanceert DARE-NL (in Dutch)

6 December, 2021/by admin